A Diagnostic Tool for Smith-Lemli-Opitz Syndrome

Application Notes

A Diagnostic Tool for Smith-Lemli-Opitz Syndrome

Capillary GC/FID used to separate cholesterol and precursor molecule in plasma to identify genetic defect.

A Diagnostic Tool for Smith-Lemli-Opitz Syndrome, Alltech Application Note #AN104, July 6, 2004.

Smith-Lemli-Opitz syndrome is a hereditary biochemical disorder in which a gene responsible for converting 7-dehydrocholesterol to cholesterol is defective. The resulting lack of cholesterol causes severe birth defects. An elevated level of 7-dehydrocholesterol in plasma is a biochemical marker for this syndrome. Thus, a rapid method for determining both compounds in human plasma would be a useful diagnostic tool.

Both cholesterol and 7-dehydrocholesterol (33µg/mL in chloroform extracted plasma) were separated without derivatization on an Alltech Heliflex® AT-1ms, 15m x 0.25mm x 0.25µm capillary column (Part No. 15880) isothermally at 305°C using helium carrier gas and a split inlet flow. Detection was by FID at a temperature of 325°C. The separation of both compounds took about 4 minutes.